1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Key Pharma News 18 APRIL 2016

Key Pharma News 18 APRIL 2016

  • April 2016
  • -
  • Espicom Business Intelligence
  • -
  • 22 pages

Industry Trend Analysis - GSK's Access Proposal Is Bold But Implementation Will Be Key
Industry Trend Analysis - Celgene Augments Long-Term Outlook
Industry Trend Analysis - AD Acquisition Heralds Allergan's New Strategy To Drive Growth
Industry Brief - Sun Pharma Acquires Prescription Brands From Novartis In Japan
Industry Trend Analysis - Highly Novel Therapies To Capitalise On China's Innovation Drive
Industry Trend Analysis - Gilead Steps Up Drive For Transformation
Industry Trend Analysis - Roche To Make High-Impact Entry Into PD-1/PD-L1 Arena
Industry Brief - Opdivo Becomes First PD-1 Inhibitor Approved For RCC In EU
Industry Trend Analysis - Sanofi's Dengvaxia Making Inroads In Asia
Industry Trend Analysis - Enhancing Portfolios Crucial To Counter Slowing CNS Development
Industry Trend Analysis - Lialda Weathers Generic Storms But Remains At Threat From PTO Ruling
Industry Trend Analysis - ADHD Revenues Will Underpin Shire's Rare Disease Pivot
Industry Brief - Amneal Launches Diclofenac Sodium Gel
Industry Trend Analysis - Genetic Medicine Will Drive Rare Disease Success
Industry Trend Analysis - FTC Intervention Threatens Generic Marketing Exclusivity Period Value
Industry Brief - Apotex Launches Filgrastim Biosimilar
Industry Trend Analysis - US Infliximab Approval Will Be A Boon For Pfizer And Celltrion
Industry Trend Analysis - EU Glatiramer Approval Positions Synthon To Compete With Sandoz
Industry Trend Analysis - AstraZeneca To Benefit From Clovis Setback
Industry Trend Analysis - AstraZeneca And Eli Lilly Accelerate Alzheimer's Drug Development

Table Of Contents

Key Pharma News 18 APRIL 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.